Current partner codePEPTIDESDE
NCT07446933·Phase 2·INTERVENTIONAL

Vasopressin vs. Uterine Artery Clamping for Laparoscopic Cesarean Scar Niche Repair

Status

Completed

Phase

Phase 2

Enrollment

30

Locations

1

Results

Not posted

Publications

0

Study summary

What the protocol is testing.

This study evaluates two methods for controlling intraoperative bleeding during laparoscopic surgery to repair a cesarean scar niche (CSN). It compares the effectiveness of intramyometrial vasopressin injection against bilateral temporary clamping of the uterine arteries using laparoscopic bulldog clips. The goal is to determine if vasopressin injection is non-inferior to arterial clamping in reducing blood loss and maintaining surgical field visibility.

Interventions

Treatment arms and agents.

DRUG

Vasopressin Group

Patients receive a local injection of 12 mL of diluted vasopressin into the myometrium directly surrounding the cesarean scar niche. This is performed during the laparoscopic procedure, just before the excision of the fibrous scar tissue, to constrict local blood vessels and minimize intraoperative bleeding.

PROCEDURE

Bulldog Clamping Group

This intervention involves the temporary mechanical clamping of both uterine arteries using laparoscopic bulldog vascular clips. The clips are applied to block blood flow to the uterus before the niche is excised and are removed once the myometrial reconstruction is complete.

PROCEDURE

Standard of Care

Approach: A 3-port laparoscopic approach using Storz endoscopic instruments. Excision: Complete removal of the fibrous scar tissue surrounding the niche defect. Reconstruction: Suturing and repair of the myometrium to resolve the defect.

Timeline

From registration to results.

  1. First posted

    Mar 3, 2026

  2. Study start

    Mar 20, 2024

  3. Primary completion

    Oct 17, 2025

  4. Study completion

    Jan 15, 2026

  5. Results posted

    Not reported

  6. Registry updated

    Mar 3, 2026

Outcomes

What the study measures.

Primary outcomes

Mean Hemoglobin Deficit Mean Hemoglobin Deficit

Time frame · 24 hours post-surgery.

The difference between preoperative and postoperative hemoglobin concentrations, used as a primary indicator of intraoperative blood loss.

Secondary outcomes

Surgical Field Visibility (SFV) Score

Time frame · Intraoperative

Assessment of the clarity of the surgical field using Boezaart's scale (0-5), where lower scores indicate better visibility.

Total Operative Time

Time frame · Intraoperative

Duration of the surgical procedure from the initial incision to the completion of myometrial reconstruction.

Eligibility

Who can take part.

Minimum age
21 Years
Maximum age
45 Years
Sex
FEMALE
Healthy volunteers
Yes

Inclusion Criteria: * Diagnosis of symptomatic CSN. * Scheduled for laparoscopic excision and repair. Exclusion Criteria: * Contraindications to vasopressin (e.g., severe hypertension or cardiovascular disease). * Presence of other major uterine pathologies (e.g., large myomas or malignancy).

Study locations

1 registered sites.

Saudi Arabia. Showing up to 24 locations stored in the fast local snapshot.

Dr. Samir Abbas Hospital

Jeddah, Saudi Arabia

Publications

Results and literature.

No PMID-linked publications were present in this registry snapshot.

Primary links

Continue at the source.

Related trials

More studies on Vasopressin.

Related PeptideStat pages

Put the record in context.

Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.